Company page

Oculis Holding Ag

Oculis Holding AG is a public company traded under the ticker OCS in the American market. With a market capitalization of approximately $636.3 million, the company focuses on developing innovative ophthalmic therapies. Oculis aims to address unmet medical needs in eye care through its advanced drug delivery systems and formulations.